Search Results - "Mead, Graham M"

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 by BELLMUNT, Joaquim, VON DER MAASE, Hans, WINQUIST, Eric, RAGHAVAN, Derek, MARREAUD, Sandrine, COLLETTE, Sandra, SYLVESTER, Richard, DE WIT, Ronald, MEAD, Graham M, SKANECZNA, Iwona, DE SANTIS, Maria, DAUGAARD, Gedske, BOEHLE, Andreas, CHEVREAU, Christine, PAZ-ARES, Luis, LAUFMAN, Leslie R

“…The combination of gemcitabine plus cisplatin (GC) is a standard regimen in patients with locally advanced or metastatic urothelial cancer. A phase I/II study…”
Get full text

Randomized Trial of Carboplatin Versus Radiotherapy for Stage I Seminoma: Mature Results on Relapse and Contralateral Testis Cancer Rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214) by OLIVER, R. Timothy D, MEAD, Graham M, RUSTIN, Gordon J. S, JOFFE, Johnathan K, AASS, Nina, COLEMAN, Robert, GABE, Rhian, POLLOCK, Philip, STENNING, Sally P

“…Initial results of a randomized trial comparing carboplatin with radiotherapy (RT) as adjuvant treatment for stage I seminoma found carboplatin had a…”
Get full text

Randomized Trial of 30 Versus 20 Gy in the Adjuvant Treatment of Stage I Testicular Seminoma: A Report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328) by JONES, William G, FOSSA, Sophie D, MEAD, Graham M, ROBERTS, J. Trevor, SOKAL, Michael, HORWICH, Alan, STENNING, Sally P

“…To assess the possibility of reducing radiotherapy doses without compromising efficacy in the management of patients with stage I seminoma. Patients were…”
Get full text

Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group by RUSTIN, Gordon J, MEAD, Graham M, STENNING, Sally P, VASEY, Paul A, AASS, Nina, HUDDART, Robert A, SOKAL, Michael P, JOFFE, Jonathan K, HARLAND, Stephen J, KIRK, Sarah J

“…Surveillance is a standard management approach for stage I nonseminomatous germ cell tumors (NSGCT). A randomized trial of two versus five computed tomography…”
Get full text

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group by Huddart, Robert A, O'Doherty, Michael J, Padhani, Anwar, Rustin, Gordon J S, Mead, Graham M, Joffe, Johnathan K, Vasey, Paul, Harland, Stephen J, Logue, John, Daugaard, Gedske, Hain, Sharon F, Kirk, Sarah J, MacKewn, Jane E, Stenning, Sally P

“…There are several management options for patients with clinical stage I (CS1) nonseminomatous germ cell tumors (NSGCT); this study examined whether an…”
Get full text

Equivalence of Three or Four Cycles of Bleomycin, Etoposide, and Cisplatin Chemotherapy and of a 3- or 5-Day Schedule in Good-Prognosis Germ Cell Cancer: A Randomized Study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council by DE WIT, Ronald, ROBERTS, J. Trevor, WILKINSON, Peter M, DE MULDER, Pieter H. M, MEAD, Graham M, FOSSA, Sophie D, COOK, Pat, DE PRIJCK, Linda, STENNING, Sally, COLLETTE, Laurence

“…To test the equivalence of three versus four cycles of bleomycin, etoposide, and cisplatin (BEP) and of the 5-day schedule versus 3 days per cycle in…”
Get full text

Quality of Life in Good Prognosis Patients With Metastatic Germ Cell Cancer: A Prospective Study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20) by FOSSA, Sophie D, DE WIT, Ronald, BOTTOMLEY, Andrew, COLLETTE, Laurence, ROBERTS, J. Trevor, WILKINSON, Peter M, DE MULDER, Pieter H. M, MEAD, Graham M, COOK, Pat, DE PRIJCK, Linda, STENNING, Sally, AARONSON, Neil K

“…To describe global quality of life (GLQL) in patients with metastatic testicular cancer (TC) treated with four different schedules of bleomycin, etoposide, and…”
Get full text

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial) by Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.

“…This prospective study aimed to develop reproducible diagnostic criteria for sporadic Burkitt lymphoma (BL), applicable to routine practice, and to evaluate…”
Get full text

Randomized Trials in 2466 Patients With Stage I Seminoma: Patterns of Relapse and Follow-up by MEAD, Graham M, FOSSA, Sophie D, OLIVER, R. Timothy D, JOFFE, Johnathan K, HUDDART, Robert A, ROBERTS, J. Trevor, POLLOCK, Philip, GABE, Rhian, STENNING, Sally P

“…From July 1, 1989, through March 31, 2001, 2466 patients with stage I seminoma were evaluated in three randomized noninferiority trials: the TE10, TE18, and…”
Get full text

The clinical features and management of testicular germ cell tumours in patients aged 60 years and older by Wheater, Matthew J., Manners, James, Nolan, Luke, Simmonds, Peter D., Hayes, Matthew C., Mead, Graham M.

“…Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject ? and What does the study add? The treatment of younger men with testicular…”
Get full text

Enteropathy-Type Intestinal T-Cell Lymphoma: Clinical Features and Treatment of 31 Patients in a Single Center by GALE, J, SIMMONDS, P. D, MEAD, G. M, SWEETENHAM, J. W, WRIGHT, D. H

“…We report the clinical features and treatment of 31 patients with a diagnosis of enteropathy-type intestinal T-cell lymphoma treated at the Wessex Regional…”
Get full text

Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma by Wheater, Matthew J, Mead, Graham M, Bhandari, Sandeep, Fennell, Jonathan

Get full text

A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma : Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy by MEAD, Graham M, BLEEHEN, Norman M, MOSS, Timothy H, BRADA, Michael, WHALEY, Jill B, STENNING, Sally P, GREGOR, Anna, BULLIMORE, Jill, MURRELL, D. Shirley, RAMPLING, Roy P, ROBERTS, J. Trevor, GLASER, Mark G, LANTOS, Peter, IRONSIDE, James W

“…The role of chemotherapy in the treatment of patients with primary central nervous system lymphoma (PCL) remains unclear, with no randomized trials available…”
Get full text

Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B‐cell lymphoma by Kerr, Jonathan P., Turner, Mandy, Ashton‐Key, Margaret, Mead, Graham M., Johnson, Peter W. M.

Get full text

The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part II: metastatic disease by Mead, Graham M., Roberts, J. Trevor

Get full text

The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part I: locally advanced disease by Mead, Graham M., Roberts, J. Trevor

Get full text

The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland by O'Callaghan, Ann M., Katapodis, Ourania, Ellison, David W., Theaker, Jeffrey M., Mead, Graham M.

“…BACKGROUND The growing teratoma syndrome is a recognized complication of metastatic nonseminomatous germ cell tumors of the testis and is managed surgically…”
Get full text

Recombinant Factor Vila in the Management of Pulmonary Hemorrhage Associated With Metastatic Choriocarcinoma by WHEATER, Matthew J, MEAD, Graham M, BHANDARI, Sandeep, FENNELL, Jonathan

Get full text

Response: Bone marrow involvement and outcome in Burkitt lymphoma and diffuse large B-cell lymphoma by Jack, Andrew S., Barrans, Sharon L., Qian, Wendi, Stenning, Sally P., Mead, Graham M.

Get full text

Impact of the Treating Institution on Survival of Patients With“Poor-Prognosis” Metastatic Nonseminoma by Collette, Laurence, Sylvester, Richard J., Stenning, Sally P., Fossa, Sophie D., Mead, Graham M., de Wit, Ronald, de Mulder, Pieter H. M., Neymark, Niels, Lallemand, Eric, Kaye, Stanley B.

“…BACKGROUND: Because metastatic nonseminomatous germ cell cancer is a rare but treatable cancer, we have explored whether there is an association between the…”
Get full text